Cara Therapeutic Stock Target Price and Analyst Consensus

CARA Stock  USD 0.94  0.07  8.56%   
The current analyst and expert consensus on Cara Therapeutic is Strong Buy, with 3 strong buy opinions. The current projected Cara Therapeutic target price consensus is 14.29 with 6 analyst opinions. The most common way Cara Therapeutic analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Cara Therapeutic executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Cara Therapeutic. We strongly encourage you to use your own analysis of Cara Therapeutic to validate this buy or sell advice. Cara Therapeutic buy-or-sell recommendation module provides average expert sentiment on the projected Cara Therapeutic target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Cara Therapeutic to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.
Lowest Forecast
13
Highest Forecast
15.86
Target Price
14.29
The current year's Gross Profit Margin is expected to grow to 0.73, whereas Gross Profit is forecasted to decline to about 14.2 M. At present, Cara Therapeutic's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 45.3 M, whereas Other Current Liabilities is forecasted to decline to about 7.4 M.
  
It's important to approach Cara Therapeutic's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Cara Therapeutic price targets

Cara Therapeutic's stock target price is an estimate of its future price, usually made by analysts. Using Cara Therapeutic's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Cara Therapeutic's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Cara Therapeutic's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Cara Therapeutic Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cara Therapeutic is a key component of Cara Therapeutic valuation and have some predictive power on the future returns of a Cara Therapeutic.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cara Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.898.29
Details
Intrinsic
Valuation
LowRealHigh
0.214.1811.58
Details
Naive
Forecast
LowNextHigh
0.020.798.19
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.43-0.4-0.35
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cara Therapeutic. Your research has to be compared to or analyzed against Cara Therapeutic's peers to derive any actionable benefits. When done correctly, Cara Therapeutic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cara Therapeutic.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested few shares
Cash Cows Idea
Cash Cows
Invested a lot of shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
When determining whether Cara Therapeutic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cara Therapeutic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cara Therapeutic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cara Therapeutic Stock:
Check out Macroaxis Advice on Cara Therapeutic to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Cara Stock analysis

When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
The data published in Cara Therapeutic's official financial statements usually reflect Cara Therapeutic's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cara Therapeutic. For example, before you start analyzing numbers published by Cara accountants, it's critical to develop an understanding of what Cara Therapeutic's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Cara Therapeutic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cara Therapeutic's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cara Therapeutic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cara Therapeutic. Please utilize our Beneish M Score to check the likelihood of Cara Therapeutic's management manipulating its earnings.